Cargando…

The intrarenal landscape of T cell receptor repertoire in clear cell renal cell cancer

BACKGROUND: Clear cell renal cell cancer (ccRCC) is accompanied by T-cell infiltration. In this study, we sought to determine the difference in T-cell infiltration and the T-cell receptor (TCR) immune repertoire between ccRCC and peritumour tissue. METHODS: T-cell infiltration was examined using imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wei, Zhang, Qian, Zhu, Chao, Shi, Zhiyuan, Shao, Chen, Chen, Yujie, Wang, Nan, Jiang, Yanxia, Liang, Qing, Wang, Kejia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719196/
https://www.ncbi.nlm.nih.gov/pubmed/36463235
http://dx.doi.org/10.1186/s12967-022-03771-3
_version_ 1784843266747793408
author Zhang, Wei
Zhang, Qian
Zhu, Chao
Shi, Zhiyuan
Shao, Chen
Chen, Yujie
Wang, Nan
Jiang, Yanxia
Liang, Qing
Wang, Kejia
author_facet Zhang, Wei
Zhang, Qian
Zhu, Chao
Shi, Zhiyuan
Shao, Chen
Chen, Yujie
Wang, Nan
Jiang, Yanxia
Liang, Qing
Wang, Kejia
author_sort Zhang, Wei
collection PubMed
description BACKGROUND: Clear cell renal cell cancer (ccRCC) is accompanied by T-cell infiltration. In this study, we sought to determine the difference in T-cell infiltration and the T-cell receptor (TCR) immune repertoire between ccRCC and peritumour tissue. METHODS: T-cell infiltration was examined using immunohistochemistry (IHC) and haematoxylin and eosin (HE) staining. The chi-squared test and Pearson correlation analysis were applied to evaluate the relationship between clinical traits and CD3, CD4, and CD8 expression. Immune repertoire sequencing (IR-Seq) was used to describe the profile of the TCR repertoire. RESULTS: The adjacent tissue showed increased expression of CD3, CD4 and CD8 compared with ccRCC tissue (P(CD3) = 0.033; P(CD4) = 0.014; P(CD8) = 0.004). Indicated CD3(+) T-cell density in ccRCC tissue was positively correlated with that in peritumour tissue (P = 0.010, r = 0.514), which implied the T cells in peritumour tissue directly infect the number of cells infiltrating in ccRCC tissue. Moreover, there was a positive correlation between Vimentin expression and indicated positive T-cell marker in ccRCC tissue (P(CD3) = 0.035; P(CD4) = 0.020; P(CD8) = 0.027). Advanced stage revealed less CD4(+) T-cell infiltration in ccRCC tissue (P(CD4) = 0.023). The results from IR-Seq revealed an obvious increase in VJ and VDJ segment usage, as well as higher complementarity-determining region 3 (CDR3) amino acid (aa) clonotypes in ccRCC. The matched antigen recognized by the TCR of ccRCC may be potential targets. CONCLUSIONS: The current study collectively demonstrates diminished T-cell infiltration and increased CDR3 aa diversity in ccRCC, which may be associated with immunotherapeutic targets for ccRCC patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-022-03771-3.
format Online
Article
Text
id pubmed-9719196
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97191962022-12-04 The intrarenal landscape of T cell receptor repertoire in clear cell renal cell cancer Zhang, Wei Zhang, Qian Zhu, Chao Shi, Zhiyuan Shao, Chen Chen, Yujie Wang, Nan Jiang, Yanxia Liang, Qing Wang, Kejia J Transl Med Research BACKGROUND: Clear cell renal cell cancer (ccRCC) is accompanied by T-cell infiltration. In this study, we sought to determine the difference in T-cell infiltration and the T-cell receptor (TCR) immune repertoire between ccRCC and peritumour tissue. METHODS: T-cell infiltration was examined using immunohistochemistry (IHC) and haematoxylin and eosin (HE) staining. The chi-squared test and Pearson correlation analysis were applied to evaluate the relationship between clinical traits and CD3, CD4, and CD8 expression. Immune repertoire sequencing (IR-Seq) was used to describe the profile of the TCR repertoire. RESULTS: The adjacent tissue showed increased expression of CD3, CD4 and CD8 compared with ccRCC tissue (P(CD3) = 0.033; P(CD4) = 0.014; P(CD8) = 0.004). Indicated CD3(+) T-cell density in ccRCC tissue was positively correlated with that in peritumour tissue (P = 0.010, r = 0.514), which implied the T cells in peritumour tissue directly infect the number of cells infiltrating in ccRCC tissue. Moreover, there was a positive correlation between Vimentin expression and indicated positive T-cell marker in ccRCC tissue (P(CD3) = 0.035; P(CD4) = 0.020; P(CD8) = 0.027). Advanced stage revealed less CD4(+) T-cell infiltration in ccRCC tissue (P(CD4) = 0.023). The results from IR-Seq revealed an obvious increase in VJ and VDJ segment usage, as well as higher complementarity-determining region 3 (CDR3) amino acid (aa) clonotypes in ccRCC. The matched antigen recognized by the TCR of ccRCC may be potential targets. CONCLUSIONS: The current study collectively demonstrates diminished T-cell infiltration and increased CDR3 aa diversity in ccRCC, which may be associated with immunotherapeutic targets for ccRCC patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-022-03771-3. BioMed Central 2022-12-03 /pmc/articles/PMC9719196/ /pubmed/36463235 http://dx.doi.org/10.1186/s12967-022-03771-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhang, Wei
Zhang, Qian
Zhu, Chao
Shi, Zhiyuan
Shao, Chen
Chen, Yujie
Wang, Nan
Jiang, Yanxia
Liang, Qing
Wang, Kejia
The intrarenal landscape of T cell receptor repertoire in clear cell renal cell cancer
title The intrarenal landscape of T cell receptor repertoire in clear cell renal cell cancer
title_full The intrarenal landscape of T cell receptor repertoire in clear cell renal cell cancer
title_fullStr The intrarenal landscape of T cell receptor repertoire in clear cell renal cell cancer
title_full_unstemmed The intrarenal landscape of T cell receptor repertoire in clear cell renal cell cancer
title_short The intrarenal landscape of T cell receptor repertoire in clear cell renal cell cancer
title_sort intrarenal landscape of t cell receptor repertoire in clear cell renal cell cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719196/
https://www.ncbi.nlm.nih.gov/pubmed/36463235
http://dx.doi.org/10.1186/s12967-022-03771-3
work_keys_str_mv AT zhangwei theintrarenallandscapeoftcellreceptorrepertoireinclearcellrenalcellcancer
AT zhangqian theintrarenallandscapeoftcellreceptorrepertoireinclearcellrenalcellcancer
AT zhuchao theintrarenallandscapeoftcellreceptorrepertoireinclearcellrenalcellcancer
AT shizhiyuan theintrarenallandscapeoftcellreceptorrepertoireinclearcellrenalcellcancer
AT shaochen theintrarenallandscapeoftcellreceptorrepertoireinclearcellrenalcellcancer
AT chenyujie theintrarenallandscapeoftcellreceptorrepertoireinclearcellrenalcellcancer
AT wangnan theintrarenallandscapeoftcellreceptorrepertoireinclearcellrenalcellcancer
AT jiangyanxia theintrarenallandscapeoftcellreceptorrepertoireinclearcellrenalcellcancer
AT liangqing theintrarenallandscapeoftcellreceptorrepertoireinclearcellrenalcellcancer
AT wangkejia theintrarenallandscapeoftcellreceptorrepertoireinclearcellrenalcellcancer
AT zhangwei intrarenallandscapeoftcellreceptorrepertoireinclearcellrenalcellcancer
AT zhangqian intrarenallandscapeoftcellreceptorrepertoireinclearcellrenalcellcancer
AT zhuchao intrarenallandscapeoftcellreceptorrepertoireinclearcellrenalcellcancer
AT shizhiyuan intrarenallandscapeoftcellreceptorrepertoireinclearcellrenalcellcancer
AT shaochen intrarenallandscapeoftcellreceptorrepertoireinclearcellrenalcellcancer
AT chenyujie intrarenallandscapeoftcellreceptorrepertoireinclearcellrenalcellcancer
AT wangnan intrarenallandscapeoftcellreceptorrepertoireinclearcellrenalcellcancer
AT jiangyanxia intrarenallandscapeoftcellreceptorrepertoireinclearcellrenalcellcancer
AT liangqing intrarenallandscapeoftcellreceptorrepertoireinclearcellrenalcellcancer
AT wangkejia intrarenallandscapeoftcellreceptorrepertoireinclearcellrenalcellcancer